SILICON Therapeutics Logo (WIPO, 11.01.2022)
WIPOSchützen Sie diese Marke vor Nachahmern!
Mit unserer Markenüberwachung werden Sie automatisch per E-Mail über Nachahmer und Trittbrettfahrer benachrichtigt.
Die Internationale Marke SILICON Therapeutics wurde als Bildmarke am 11.01.2022 bei der Weltorganisation für geistiges Eigentum angemeldet.
Logodesign (Wiener Klassifikation)
#Kreise #Andere Polygone #Briefe, die eine besondere Form des Schreibens darstellen #Farben #Mehrere Kreise, nebeneinanderliegend, tangential oder sich überschneidend #Ein Polygon #Buchstabenreihen in verschiedenen Dimensionen #Zwei vorherrschende Farben
| Markenform | Bildmarke |
| Aktenzeichen | 1663459 |
| Länder | 
|
| Basismarke |
Nr. 97208254,
07. Januar 2022
|
| Anmeldedatum | 11. Januar 2022 |
| Ablaufdatum | 11. Januar 2032 |
Markeninhaber
151 W. 42nd Street
New York NY 10036
US
New York NY 10036
US
Markenvertreter
151 WEST 42ND STREET, 17TH FLOOR
New York NY 10036
US
Waren und Dienstleistungen
05
Pharmaceutical preparations for human use; biologic
preparations for medical and therapeutic purposes;
Pharmaceutical preparations for human use for the treatment
of central nervous system, neurological, dementia,
dermatological, metabolic, hematologic, infectious,
auto-immune, immune deficiency, genetic, hepatological,
cardiometabolic, urological, oncological, endocrine and
endocrine-related, gynecological, ophthalmological,
respiratory, cardiac, and pulmonary disorders, diseases and
conditions; Anti-cancer preparations; Pharmaceutical
preparations and substances for the prevention of cancer;
Pharmaceutical preparations and substances for the treatment
of cancer; Pharmaceutical preparations for the treatment of
cancer; Anti-cancer preparations of chemical origin;
Anti-cancer preparations of plant origin; Anti-cancer
preparations of microbial origin; Biopharmaceuticals for the
treatment of cancer; Compounds for treating cancer;
Biological preparations for medical purposes; Biological
preparations for the treatment of cancer; Viral vaccines;
Pharmaceutical preparations for the treatment of viral
diseases; Pharmaceutical preparations for the treatment of
inflammatory diseases; Pharmaceutical preparations for the
prevention of inflammatory diseases; Pharmaceuticals;
Chemico-pharmaceutical preparations; Antibacterial
pharmaceuticals; Anti-microbial preparations; Chemical
preparations for medical purposes; Chemical preparations for
pharmaceutical purposes; Vaccines; Vaccine adjuvants;
Pharmaceutical preparations comprising small molecules for
degrading disease-causing cellular proteins for treatment in
the field of oncology; pharmaceutical and biological
preparations for treatment and prevention of cancer and for
the treatment and prevention of auto-immune diseases and
disorders and central nervous system and neurological
diseases and disorders; Biological preparations for the
treatment of viral infections; Biological preparations for
the treatment of inflammatory conditions; Biological
preparations for the treatment of age-related degenerative
diseases; Biological preparations for the treatment of
microbial, fungal and viral infections; Chemical
preparations for pharmaceutical or medical purposes, namely,
for the treatment of age-related degenerative diseases and
cancers; Pharmaceutical preparations for the treatment and
prevention of cancer; Pharmaceutical preparations for the
treatment and prevention of viral infections; Pharmaceutical
preparations for the treatment and prevention of microbial,
fungal and viral infections; Pharmaceutical preparations for
the treatment and prevention of inflammatory conditions;
Pharmaceutical preparations for the treatment and prevention
of age-related degenerative diseases; Vaccine preparations
42
Scientific and technological services and research and
design relating thereto; research in the fields of
pharmaceutical and biologic therapeutic preparations,
clinical trials and post-market trials; biomedical research
and development; Research and development in the
pharmaceutical and biotechnology fields; Research and
development of new products; Research and development of new
products for others; Research and development of
pharmaceuticals for the treatment of age-related diseases
and cancer; Research and development of vaccines and
medicines; Research and development services in the field of
antibodies; Biochemical research and development; Consulting
services in the fields of biotechnology, pharmaceutical
research and development and genetic science; Pharmaceutical
research and development; Product research and development;
Scientific research and development; Pharmaceutical product
development for new small molecules aimed at degrading
disease-causing cellular proteins for treatment in the field
of oncology
44
Providing health and medical information; providing
information relating to the diagnostic, prophylactic and
therapeutic properties of pharmaceutical preparations and
biologic preparations for the prevention and treatment of
diseases, disorders and conditions
Die Bezeichnungen wurden automatisch übersetzt. Übersetzung anzeigen
Markenhistorie
| Datum | Belegnummer | Bereich | Eintrag |
|---|---|---|---|
| 18. Juli 2023 | 2023/29 Gaz | KR | Ablehnung |
| 17. Juli 2023 | 2023/29 Gaz | MX | Ablehnung |
| 04. Juli 2023 | 2023/27 Gaz | SG | Ablehnung |
| 29. Mai 2023 | 2023/22 Gaz | NO | Ablehnung |
| 27. April 2023 | 2023/17 Gaz | JP | Ablehnung |
| 26. April 2023 | 2023/17 Gaz | RU | RAW: Rule 18ter(2)(ii) GP following a provisional refusal |
| 15. Februar 2023 | 2023/7 Gaz | BR | Ablehnung |
| 09. November 2022 | 2022/45 Gaz | CN | Ablehnung |
| 06. Oktober 2022 | 2022/41 Gaz | IL | Ablehnung |
| 30. September 2022 | 2022/40 Gaz | RU | Ablehnung |
| 24. August 2022 | 2022/34 Gaz | GB | Ablehnung |
| 23. August 2022 | 2022/34 Gaz | AU | Ablehnung |
| 13. Juni 2022 | 2022/24 Gaz | IN | Ablehnung |
| 11. Januar 2022 | 2022/19 Gaz | US | Eintragung |
ID: 141663459